Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Galaxy Digital Inc. Class A Common Stock vs Immunovant Inc. Common Stock — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.49 (market cap $3.90B), while Immunovant Inc. Common Stock trades at $30.3 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| GLXY | IMVT | |
|---|---|---|
Market Cap | $3.90B | $6.25B |
Volume | 7,887,173 | 1,755,411 |
Sector | Financials | Health |
52-Week High | $42.86 | $44.96 |
52-Week Low | $16.84 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.36B | $5.35B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Galaxy Digital Inc. Class A Common Stock
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
